Adult Dosing & Uses
Tetanus Immunization
DT: 0.5 mL IM (Td) q10Years
Other Indications & Uses
DT: Children with serious reactions to DTP
Td: Unvaccinated adults planning trips abroad
Td: Postexposure prophylaxis of Tetanus
Pediatric Dosing & Uses
Tetanus Immunization
6-8 weeks: 0.5 mL (DT) x 2 doses IM q4-8Weeks and 3rd dose 6-12 months later
>7 years old: 0.5 mL IM (Td) x 2 doses q4-8Weeks and 3rd dose 6-12 months later
Other Indications & Uses
DT: Children with serious reactions to DTP
Td: Unvaccinated adults planning trips abroad
Td: Postexposure prophylaxis of Tetanus
Drug Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Adverse Effects
Suspected adverse events after administration of any vaccine may be reported to Vaccine Adverse Events Reporting System (VAERS), 1-800-822-7967
Frequency Not Defined
Fever
Tenderness, pain, redness, swelling at inj site
Arthus reaction (rare)
Contraindications & Cautions
Contraindications
Hypersensitivity to a previous dose, Thimerosal
Pregnancy & Lactation
Pregnancy Category:C
Lactation: excretion in milk unknown; use with caution
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Pharmacology
These products convey active immunity via stimulation of production of endogenously produced antibodies
The onset of protection from disease is relatively slow, but duration is long lasting (years)
Duration >10 yr
Mechanism of Action
Toxoid stimulation of active immunity
